Immediately Loaded Bar-Connected Implants with an Anodized Surface Inserted in the Anterior Mandible in a Patient Treated with Diphosphonates for Osteoporosis: A Case Report with a 12-Month Follow-Up

Clinical Implant Dentistry and Related Research

Volumn 5, Issue 4, 2003, Pages 269-272

  Degidi, Marco ^a,b   Piattelli, Adriano ^b  

^a University of Chieti ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Diphosphonates; Implant failure; Implant treatment; Osteoporosis

Indexed keywords

ETIDRONIC ACID;

ADULT; ARTICLE; BONE REGENERATION; CASE REPORT; DENTURE; FEMALE; FOLLOW UP; HUMAN; IMPLANT; MANDIBLE; OSTEOLYSIS; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PROSTHESIS LOOSENING; SURFACE PROPERTY; TOOTH IMPLANTATION; TREATMENT OUTCOME;

EID: 1342302779     PISSN: 15230899     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8208.2003.tb00210.x     Document Type: Article

References (27)

1. Fujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with osteoporosis: a case report. Int J Oral Maxillofac Implants 1996; 11:539-542.
2. Eder A, Watzek G. Treatment of a patient with severe osteoporosis and chronic polyarthritis with fixed implant-supported prosthesis: a case report. Int J Oral Maxillofac Implants 1999; 14:587-590.
3. Stark WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report. Int J Oral Maxillofac Implants 1995; 10:74-78.
4. Becker W, Hyjoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: an exploratory case-control study. J Periodontol 2000; 71:625-631.
5. Friberg B, Ekestubbe A, Mellstrom D, Sennerby L. Brånemark implants and osteoporosis: a clinical exploratory study. Clin Implant Dent Relat Res 2001; 3:50-56.
6. von Wovern N. General and oral aspects of osteoporosis: a review. Clin Oral Invest 2001; 5:71-82.
7. Ezra A, Golomb G. Administration routes and delivery systems of biphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 2000; 42:175-195.
8. Chlebowski RT. Factors influencing the role of biphosphonates in breast cancer management. Semin Oncol 2001; 28: 42-48.
9. Denissen H, Martinetti R, van Lingen A, van der Hooff A. Normal osteoconduction and repair in and around submerged highly biphosphonate- complexed hydroxyapatite implants in rat tibiae. J Periodontol 2000; 71:272-278.
10. Frith JC, Monkonen J, Auriola S, Monkonen H, Rogers MJ. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclasts and macrophage apoptosis. Arthritis Rheum 2001; 44:2201-2210.
11. Hiraga T, Williams PS, Mundy GR, Yoneda T. The biphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 2001; 61:4418-4424.
12. Varghese S, Canalis E. Alendronate stimulates collagenase 3 expression in osteoblasts by posttranscriptional mechanisms. J Bone Miner Res 2000; 15:2345-2351.
13. Clohisy DR, O'Keefe PF, Ramnaraine ML. Pamidronate decreases tumor-induced osteoclastogenesis in osteoperotic mice. J Orthop Res 2001; 19:554-558.
14. Ito M, Amizuka N, Nakajima T, Ozawa H. Biphosphonate acts on osteoclasts independent of ruffled borders in osteosclerotic (oc/oc) mice. Bone 2001; 28:609-616.
15. Rogers MJ, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of biphosphonates. Cancer 2000; 88:2961-2978.
16. D'Aout P, McCulloch CA, Tenenbaum HC, Lekic PC. Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria. Cell Tissue Res 2000; 302: 353-363.
17. Reinholz GG, Getz B, Pederson L, et al. Biphosphonates directly regulate cell proliferation, differentiation and gene expression in human osteoblasts. Cancer Res 2000; 60: 6001-6007.
18. Denissen H, Montanari C, Martinetti R, van Lingen A, van der Hooff A. Alveolar bone response to submerged biphosphonate-complexed hydroxyapatite implants. J Periodontol 2000; 71:279-286.
19. Payne AGT, Tawse-Smith A, Kumara R, Murray Thomson W. One-year prospective evaluation of the early loading of unsplinted conical Brånemark fixtures with mandibular overdentures immediately following surgery. Clin Implant Dent Relat Res 2001; 3:9-18.
20. Ericsson I, Randow K, Nilner K, Peterson A. Early functional loading of Brånemark dental implants: 5-year clinical follow-up study. Clin Impl Dent Rel Res 2000; 2:70-77.
21. Lazzara RJ, Porter SS, Testori T, Galante J, Zetterquist L. A prospective multicenter study evaluating loading of Osseotite® implants two months after placement: one-year results. J Esthet Dent 1998; 6:280-289.
22. Malò P, Rangert B, Dvarsater L. Immediate function of Brånemark implants in the esthetic zone: a retrospective clinical study with 6 months to 4 years of follow-up. Clin Implant Dent Relat Res 2000; 2:138-146.
23. Jo HY, Hobo PK, Hobo S. Freestanding and multiunit immediate loading of the expandable implant: an up-to-40 months prospective survival study. J Prosthet Dent 2001; 85:148-155.
24. Grunder U. Immediate functional loading of immediate implants in edentulous arches: two-year results. Int J Periodontics Restorative Dent 2001; 21:545-551.
25. Hall J, Lausmaa J. Properties of a new porous oxide surface on titanium implants. Applied Osseointegration Research 2000; 1:5-8.
26. Henry PJ, Tan AES, Allan BP, Hall J, Johanssen C. Removal torque comparison of TiUnite and turned implants in the greyhound dog. Applied Osseointegration Research 2000; 1:15-17.
27. Albrektsson T, Johansson C, Lundgren AK, Sul YT, Gottlow J. Experimental studies on oxidized implants. A histomorphometrical and biomechanical analysis. Applied Osseointegration Research 2000; 1:21-24.